The Diagnosis and Treatment of Colorectal Gastrointestinal Stromal Tumors

徐烨,程晓斌,林建江,徐加鹤,王金海,刘凡隆,徐向明,陈文斌

DOI: https://doi.org/10.3760/cma.j.issn.1007-631x.2013.01.004

2013-01-01

Abstract:Objective To assess the clinicopathological features,treatment and prognosis of colorectal gastrointestinal stromal tumors (GISTs).Methods Clinical data of 49 patients diagnosed as colorectal GISTs between December 2000 and September 2009 were reviewed.The major clinicopathological features,treatment modalities and outcomes were retrospectively analyzed.Analysis of variarance (ANOVA)was applied to measurement data,while x2 or Fisher's exact test was assigned to enumeration data.The survival analysis was applied to estimate the prognosis of 49 patients undergoing operative treatment.Results The median age of the patients was 54 years old.There was no significant sexual deference in the incidence (49％ vs.51％).The onset of colorectal GISTs was insidious and the clinical symptoms were nonspecific.Main complain involved changes of defecation habit and fecal property,abdominal discomfort and bloody stool.Pathological signs of colorectal GISTs under microscope are spindle cells in beam form or knitting shape,and immunohistochemical characteristics shows the highly positive expression rates of CD117 and CD34.The recurrence rate in high risk patients after complete tumor resection is significantly higher than that in low risk (P =0.018),and the tumor-free survival time is also respectively shorter (P =0.011).Conclusions Clinical symptoms don't contribute much to the diagnosis of colorectal GISTs,while immunohistochemical staining is reliable in the identification of colorectal GISTs.Patients classified into very low and low risk groups can be cured with local excisions,while those in moderate or high risk group are recommended for radical excisions.The combination of complete resection and imatinib is recommended for a better prognosis.